ArticleACS medicinal chemistry letters2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8.
Philippe Bergeron et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it